跳至主要内容
临床试验/CTRI/2024/03/063853
CTRI/2024/03/063853尚未招募3 期

Dexamethasone versus N-acetylcysteine for the reduction of post-embolization syndromefollowing trans-arterial chemoembolization for Hepatocellular Carcinoma: a randomizedcontrolled trial (DANCES trial- DexAmethasone versus NAC for Post-EmbolizationSyndrome) - DANCE

AIIMS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
AIIMS

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All consecutive patients presenting to the Liver Clinic of the Department of Gastroenterology
  • and Human Nutrition, with cirrhosis and HCC in BCLC stages A-C who are being considered for
  • TACE will be screened for inclusion and will be included after informed consent

排除标准

  • 1. Allergy to contrast media
  • 2. Main portal vein tumor thrombosis (PVTT)-VP4
  • 3. Extrahepatic disease extension of HCC
  • 4. Child Turcotte Pugh score greater than 9
  • 5. Renal failure
  • 6. Those already on steroids for any other disease e.g. autoimmune hepatitis
  • 7. Active bacterial infection at the time of randomization
  • 8. Bilirubin greater than 3 mg per dL
  • 9. Pregnancy
  • 10. Age less than 18 years

研究者

发起方
AIIMS

相似试验